Tebapivat Matched Placebo clinical trials

A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)

This study is testing a new medicine called tebapivat for sickle cell disease. Researchers want to see if it helps improve anaemia and if different doses have different effects, compared to a dummy medicine (placebo).